Focus: QIAGEN is a global leader in diagnostics and molecular testing, with a workforce of 5,001–10,000 employees headquartered in Hilden, Germany. The company operates as a publicly traded entity (NASDAQ: QGEN) focused on clinical and research diagnostics across infectious disease, oncology, and specialty testing.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Hot — 98 jobs added in 30d
Net +57 (98 new, 41 removed). Aggressive expansion phase.
QIAGEN is a solid choice for commercial, engineering, and data-science careers in diagnostics, but offers limited depth for drug-development scientists seeking a traditional pharma pipeline experience.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for QIAGEN
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from QIAGEN's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles